Diaphragm pacing systems for amyotrophic lateral sclerosis / motor neuron disease
Información
- DOI:
- https://doi.org/10.1002/14651858.CD011222Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 20 noviembre 2014see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Neuromuscular
- Copyright:
-
- Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Contribution of author(s) (Protocol Stage)
CM is the guarantor of the review.
CM co‐ordinated the review.
CMD, DH, and CM drafted the title.
CMD, CM, DH, AR and PJS conceived the protocol.
CM, CMD and DH drafted the protocol.
CM, CMD, DH, AR and PJS reviewed and approved the protocol prior to submission.
Sources of support
Internal sources
-
Clinical Trials Research Unit, University of Sheffield, UK.
-
Sheffield Institute for Translational Neuroscience, University of Sheffield, UK.
External sources
-
Royal London Hospital, London, UK.
Declarations of interest
DH: DH is the Assistant Director of the Clinical Trials Unit where a National Institute of Health Research Health Technology Assessment (NIHR HTA) and Motor Neurone Disease Association/Henry Smith Charity funded study investigating the role of Diaphragmatic Pacing in ALS (DiPALS) is being co‐ordinated. Trial equipment has been provided by Synapse. DH is not directly involved with the trial
CM: CM is the study manager for a National Institute of Health Research Health Technology Assessment (NIHR HTA) and Motor Neurone Disease Association/ Henry Smith Charity funded study investigating the role of Diaphragmatic Pacing in ALS (DiPALS). This study has also received support from Synapse Biomedical in the form of pacing devices provided at no cost and technical support relating to device implantation and malfunction.
CJM: CJM is the chief investigator for a NIHR HTA and Motor Neurone Disease Association funded study investigating the role of Diaphragmatic Pacing in ALS. This study has also received support from Synapse Biomedical in the form of pacing devices provided at no cost and technical support relating to device implantation and malfunction.
PJS: PJS is an investigator for a NIHR HTA and Motor Neurone Disease Association funded study investigating the role of Diaphragmatic Pacing in ALS. This study has also received support from Synapse Biomedical in the form of pacing devices provided at no cost and technical support relating to device implantation and malfunction.
AR: AR is a member of the Data and Ethics Monitoring Committee for NIHR HTA funded RCT of diaphragm pacing in ALS (DiPALS).
MB: MB is the statistician for a National Institute of Health Research Health Technology Assessment (NIHR HTA) and Motor Neurone Disease Association/ Henry Smith Charity funded study investigating the role of Diaphragmatic Pacing in ALS (DiPALS). This study has also received support from Synapse Biomedical in the form of pacing devices provided at no cost and technical support relating to device implantation and malfunction.
PS: PS is the co‐investigator for the NIHR HTA and Motor Neurone Disease Association (MNDA)‐funded study investigating the role of Diaphragmatic Pacing in ALS (DiPALS). Synapse contributed equipment to her institution for use in this study.
Acknowledgements
Editorial support from the Cochrane Neuromuscular Disease group is supported by funding from the MRC Centre for Neuromuscular Disease and the Motor Neurone Disease Association. The Trials Search Co‐ordinator, Angela Gunn, developed the search strategies in collaboration with the review authors.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Nov 20 | Diaphragm pacing systems for amyotrophic lateral sclerosis / motor neuron disease | Protocol | Chin Maguire, Christopher McDermott, Daniel Hind, Aleksandar Radunovic, Pamela J Shaw | |
